|

Depression Clinical Trials in Miami, FL

48 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderPhase 3<1 mi
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive DisorderPhase 2<1 mi
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.Phase 3<1 mi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia SymptomsPhase 3<1 mi
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric PatientsPhase 3<1 mi
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)Phase 3<1 mi
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)N/A<1 mi
A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPDPhase 3<1 mi
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant DepressionN/A<1 mi
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 3<1 mi
GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive DisorderPhase 2<1 mi
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)Phase 2<1 mi
Study to Assess the Safety and Effectiveness of NMRA-335140-501Phase 3<1 mi
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)Phase 2<1 mi
Neural and Psychiatric Consequences of Cannabis Use in AdolescentsN/A<1 mi
A Study to Evaluate the Effectiveness of DT-101 in Patients With DepressionPhase 2<1 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive SymptomsPhase 4<1 mi
A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIVN/A<1 mi
ORCHID: An Online Intervention for Persons With HIV (Miami)N/A<1 mi
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) InhibitorPhase 4<1 mi
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive DisorderPhase 3<1 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive DisorderPhase 2<1 mi
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderPhase 3<1 mi
Cocooned Moms StudyN/A<1 mi
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"Phase 3<1 mi
Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in AdultsPhase 2<1 mi
The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIVN/A<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive DisorderPhase 3<1 mi
Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive DisorderPhase 3<1 mi
GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder With Comorbid Anxiety and InsomniaPhase 2<1 mi
Mental Health in Primary CareN/A<1 mi
Clinical Trial on Agitation in Alzheimer's DementiaPhase 2<1 mi
Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study—<1 mi
Families With Pride ("Familias Con Orgullo").N/A6 mi
Geolocation Positional System (GPS) ExperienceN/A6 mi
Unified Protocol: Community ConnectionsN/A6 mi
Study of ALTO-300 in MDDPhase 213 mi
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive DisorderPhase 213 mi
A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)—13 mi
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 313 mi
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 317 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II DisorderPhase 217 mi
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 317 mi
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)Phase 317 mi
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age—17 mi
The Student Wellness and Emotional Growth Resiliency (SWAG-R) ProgramN/A25 mi
A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)Phase 326 mi
ALTO-100 in Bipolar Disorder With Depression (BD-D)Phase 226 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.